John Durnell & Bayer
2 shared events · Importance 3 · Last updated Jun 26, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Regulatory
John Durnell: Plaintiff whose $1.25 million verdict was overturned; his claim was preempted. He expressed disappointment that thousands of similar cases will not proceed.
Bayer: Bayer is the primary beneficiary; the ruling shields it from thousands of failure-to-warn lawsuits, reducing litigation risk and boosting investor confidence. Shares rose ~18%.
Jun 25, 2026 · 133 articles
Regulatory
John Durnell: John Durnell is a Missouri man whose lawsuit against Bayer for developing non-Hodgkin's lymphoma after using Roundup is a key case before the United States — Supreme Court of the United States, representing thousands of similar claims.
Apr 24, 2026 · 16 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how John Durnell and Bayer interact across events, view sentiment trends, and discover connected entities.
Open Dashboard